Clinical Trials Logo
  1. Home
  2. Healthy
  3. NCT03632408
  4. Details
NCT03632408 Clinical Trial

Hangover and Residual Zopiclone Effect on Spatial Perception

Healthy Clinical Trial

— SEKO-A  

Official title:
The Effect of Alcohol Hangover and Night-time Zopiclone on Next-morning Spatial Perception in Healthy Young Volunteers

Clinical Trial Details — Status: Not yet recruiting

Administrative data
NCT number NCT03632408
Other study ID # T271
Secondary ID
Status Not yet recruiting
Phase Phase 1
First received
Last updated
Start date September 2018
Est. completion date December 2019

Study information
Verified date August 2018
Source Turku University Hospital
Contact Petri J Vainio, MD
Phone +358294504657
Email pejvai@utu.fi
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Hangover after recreational alcohol use, residual effect of zopiclone and placebo compared in terms of spatial perception, psychomotor tests and simulated driving ability. Three recording visits plus screening included.

Recruitment information / eligibility
Status Not yet recruiting
Enrollment 16
Est. completion date December 2019
Est. primary completion date May 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 35 Years
Eligibility Inclusion Criteria:

- weight >45 kg

- likely to experience and predict alcohol hangover within the next five weeks

- no childbearing potential of negative pregnancy test at screening

- a valid driving license

Exclusion Criteria:

- breastfeeding

- infection with HCV, HBV or HIV

- a medical or psychiatric condition or laboratory abnormality that may increase the risk associated with study participation

- suspected or current drug or alcohol abuse

Study Design

Related Conditions & MeSH terms

Intervention

Drug:
• Zopiclone
Oral, single dose, 7.5 mg
Behavioral:
• hangover
as per subjects choice to consume alcohol
Drug:
• Placebo oral capsule
oral

Locations
Country Name City State
Finland Teutori clinical trial facility Turku

Sponsors (2)
Lead Sponsor Collaborator
Petri Vainio University of Turku

Country where clinical trial is conducted

Finland, 

Outcome
Type Measure Description Time frame Safety issue
Primary Driving error rate Driving error rate Day 1
Primary Number of erroneous responses to peripheral visual stimuli during driving Number of erroneous responses to peripheral visual stimuli during driving Day 1
Secondary digit symbol substitution digit symbol substitution test Day 1
Secondary drug concentration concentration of zopiclone in plasma Day 1
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1